Precision Medicine

Precision Medicine is an emerging, evolving field whereby increasing amounts of different types of information are used to shape prevention, prediction, diagnosis and treatment at population, patient group and individual level. It is the way of the future.

In response to this, HISA has established a Precision Medicine Community of Practice to engage, inform and influence the HISA community and the broader health ecosystem on this important area. We want to ensure that the informatics community understands what Precision Medicine is, the initiatives internationally and here in Australia, ongoing developments in this field and the challenges it raises so that we can support its introduction into our health system. This will make us better positioned to ensure that data/information requirements and standards are understood and in place and technology solutions evolve to support the increasing use of Precision Medicine.

MembershipLeadershipResources

Precision Medicine Membership
Get Involved!

Are you interested in or involved in precision medicine? If you have suggestions, ideas or would like to get involved in this community of practice please contact us.

 

Leadership
 

Kathy Campbell

Kathy Campbell (Chair)

Director
Ockham Consulting Pty Ltd

Kate Birch

Kate Birch

Data & Technology Program Manager
Melbourne Genomics
Health Alliance

David Bunker

David Bunker

Executive Director
Queensland Genomics
Health Alliance

Dr Jon Carrano

Dr Jon Carrano 

Owner
Pharmsite

Leigh Donoghue

Leigh Donoghue

Managing Director, Health ANZ
Accenture

George Margelis

Dr George Margelis

Medical
Practitioner

Peter Williams

Peter Williams

Healthcare Innovation Advisor
Oracle

Dayna Williamson

Dayna Williamson

General Manager
Queensland Genomics
Health Alliance

Precision Medicine
Working Definition

Precision Medicine seeks and analyses a wide range of patient information, such as clinical observations, biomarkers (including genomics) and patient generated data. It triangulates this information within the context of lifestyle, behaviour, environment and medical history to inform and personalise prevention, diagnosis and treatment at an individual, patient cohort and population level. As an emerging clinical practice, precision medicine will adapt and transform over time by incorporating innovation and discovery, resulting in bespoke care.

Explanatory Notes:

Working Definition
The HISA Precision Medicine Community of Practice Steering Committee developed this working definition for the following reasons:

  • There are a number of different definitions in use internationally and around Australia
  • We want to ensure that when we, as an informatics community, have a discussion about Precision Medicine we are all talking about the same thing
  • We need a definition that is understood by our audience which has a broad range of levels of clinical understanding and a definition that may evolve over time.

Terminology
Biomarkers – A biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may also be used to see how well the body responds to a treatment for a disease or condition.
Omics – Precision Medicine includes all omics, such as genomics, proteomics or metabolomics, but for reasons of simplicity and the wide ranging understanding of our potential audience, at this stage we have only specifically mentioned genomics.